92P ARCHER 1050: PHASE III RANDOMIZED STUDY OF 1ST-LINE DACOMITINIB (D) VS GEFITINIB (G) FOR ADVANCED (ADV) NON-SMALL CELL LUNG CANCER (NSCLC) IN PATIENTS (PTS) WITH ACTIVATING EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATION(S)

✍ Scribed by Mok, T.S.K.; Nakagawa, K.; Rosell, R.; Wu, Y.; Trygstad, C.; Capizzi, R.; DeBenedetto, R.; Goldberg, Z.; Wang, T.; Antic, V.

• Book ID: 121936854
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 56 KB
• Volume: 80
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/S0169-5002(13)70311-8